TY - JOUR
T1 - Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing
AU - REIMAGINE Study Group
AU - Leite, Gabriela
AU - Rezaie, Ali
AU - Mathur, Ruchi
AU - Barlow, Gillian M.
AU - Rashid, Mohamad
AU - Hosseini, Ava
AU - Wang, Jiajing
AU - Parodi, Gonzalo
AU - Villanueva-Millan, Maria Jesus
AU - Sanchez, Maritza
AU - Morales, Walter
AU - Weitsman, Stacy
AU - Pimentel, Mark
AU - hristopher Almario, M. D.
AU - Basseri, Benjamin
AU - Chan, Yin
AU - Chang, Bianca
AU - Cheng, Derek
AU - Enayati, Pedram
AU - Gaddam, Srinivas
AU - Jamil, Laith
AU - Liu, Quin
AU - Lo, Simon
AU - Makhani, Marc
AU - Midani, Deena
AU - Noureddin, Mazen
AU - Park, Kenneth
AU - Paski, Shirley
AU - Pichetshote, Nipaporn
AU - Rabizadeh, Shervin
AU - Ross, Soraya
AU - Shaye, Omid
AU - Watson, Rabindra
N1 - Publisher Copyright:
© 2024 AGA Institute
PY - 2024/2
Y1 - 2024/2
N2 - BACKGROUND& AIMS: Despite accelerated research in small intestinal bacterial overgrowth (SIBO), questions remain regarding optimal diagnostic approaches and definitions. Here, we aim to define SIBO using small bowel culture and sequencing, identifying specific contributory microbes, in the context of gastrointestinal symptoms.METHODS: Subjects undergoing esophagogastroduodenoscopy (without colonoscopy) were recruited and completed symptom severity questionnaires. Duodenal aspirates were plated on MacConkey and blood agar. Aspirate DNA was analyzed by 16S ribosomal RNA and shotgun sequencing. Microbial network connectivity for different SIBO thresholds and predicted microbial metabolic functions were also assessed.RESULTS: A total of 385 subjects with <10
3 colony forming units (CFU)/mL on MacConkey agar and 98 subjects with ≥10
3 CFU/mL, including ≥10
3 to <10
5 CFU/mL (N = 66) and ≥10
5 CFU/mL (N = 32), were identified. Duodenal microbial α-diversity progressively decreased, and relative abundance of Escherichia/Shigella and Klebsiella increased, in subjects with ≥10
3 to <10
5 CFU/mL and ≥10
5 CFU/mL. Microbial network connectivity also progressively decreased in these subjects, driven by the increased relative abundance of Escherichia (P < .0001) and Klebsiella (P = .0018). Microbial metabolic pathways for carbohydrate fermentation, hydrogen production, and hydrogen sulfide production were enhanced in subjects with ≥10
3 CFU/mL and correlated with symptoms. Shotgun sequencing (N = 38) identified 2 main Escherichia coli strains and 2 Klebsiella species representing 40.24% of all duodenal bacteria in subjects with ≥10
3 CFU/mL.
CONCLUSIONS: Our findings confirm ≥10
3 CFU/mL is the optimal SIBO threshold, associated with gastrointestinal symptoms, significantly decreased microbial diversity, and network disruption. Microbial hydrogen- and hydrogen sulfide-related pathways were enhanced in SIBO subjects, supporting past studies. Remarkably few specific E coli and Klebsiella strains/species appear to dominate the microbiome in SIBO, and correlate with abdominal pain, diarrhea, and bloating severities.
AB - BACKGROUND& AIMS: Despite accelerated research in small intestinal bacterial overgrowth (SIBO), questions remain regarding optimal diagnostic approaches and definitions. Here, we aim to define SIBO using small bowel culture and sequencing, identifying specific contributory microbes, in the context of gastrointestinal symptoms.METHODS: Subjects undergoing esophagogastroduodenoscopy (without colonoscopy) were recruited and completed symptom severity questionnaires. Duodenal aspirates were plated on MacConkey and blood agar. Aspirate DNA was analyzed by 16S ribosomal RNA and shotgun sequencing. Microbial network connectivity for different SIBO thresholds and predicted microbial metabolic functions were also assessed.RESULTS: A total of 385 subjects with <10
3 colony forming units (CFU)/mL on MacConkey agar and 98 subjects with ≥10
3 CFU/mL, including ≥10
3 to <10
5 CFU/mL (N = 66) and ≥10
5 CFU/mL (N = 32), were identified. Duodenal microbial α-diversity progressively decreased, and relative abundance of Escherichia/Shigella and Klebsiella increased, in subjects with ≥10
3 to <10
5 CFU/mL and ≥10
5 CFU/mL. Microbial network connectivity also progressively decreased in these subjects, driven by the increased relative abundance of Escherichia (P < .0001) and Klebsiella (P = .0018). Microbial metabolic pathways for carbohydrate fermentation, hydrogen production, and hydrogen sulfide production were enhanced in subjects with ≥10
3 CFU/mL and correlated with symptoms. Shotgun sequencing (N = 38) identified 2 main Escherichia coli strains and 2 Klebsiella species representing 40.24% of all duodenal bacteria in subjects with ≥10
3 CFU/mL.
CONCLUSIONS: Our findings confirm ≥10
3 CFU/mL is the optimal SIBO threshold, associated with gastrointestinal symptoms, significantly decreased microbial diversity, and network disruption. Microbial hydrogen- and hydrogen sulfide-related pathways were enhanced in SIBO subjects, supporting past studies. Remarkably few specific E coli and Klebsiella strains/species appear to dominate the microbiome in SIBO, and correlate with abdominal pain, diarrhea, and bloating severities.
KW - Escherichia
KW - Klebsiella
KW - Metabolic Pathways
KW - Small Intestinal Bacterial Overgrowth
KW - Small Intestinal Microbiome
KW - Hydrogen
KW - Humans
KW - Escherichia coli
KW - Breath Tests
KW - Agar
KW - Gastrointestinal Diseases
KW - Hydrogen Sulfide
KW - High-Throughput Nucleotide Sequencing
UR - http://www.scopus.com/inward/record.url?scp=85162718641&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85162718641&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2023.06.001
DO - 10.1016/j.cgh.2023.06.001
M3 - Article
C2 - 37315761
AN - SCOPUS:85162718641
SN - 1542-3565
VL - 22
SP - 259
EP - 270
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 2
ER -